PortfoliosLab logoPortfoliosLab logo
NTRS vs. ARKG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NTRS vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Northern Trust Corporation (NTRS) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both investments are quite close, with NTRS having a 41.36% return and ARKG slightly higher at 42.29%. Over the past 10 years, NTRS has outperformed ARKG with an annualized return of 14.10%, while ARKG has yielded a comparatively lower 9.39% annualized return.


NTRS

1D
2.40%
1M
10.66%
6M
32.84%
YTD
41.36%
1Y
58.14%
3Y*
43.23%
5Y*
14.43%
10Y*
14.10%

ARKG

1D
0.41%
1M
17.44%
6M
26.71%
YTD
42.29%
1Y
69.42%
3Y*
4.37%
5Y*
-12.93%
10Y*
9.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NTRS vs. ARKG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NTRS
Northern Trust Corporation
41.36%36.92%25.63%-1.02%-23.82%31.65%-9.29%30.59%-14.68%14.18%
ARKG
ARK Genomic Revolution Multi-Sector ETF
42.29%23.04%-28.24%16.22%-53.90%-33.92%180.40%44.00%-1.26%46.61%

Correlation

The correlation between NTRS and ARKG is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.35

Correlation (3Y)
Calculated over the trailing 3-year period

0.42

Correlation (5Y)
Calculated over the trailing 5-year period

0.44

Correlation (10Y)
Calculated over the trailing 10-year period

0.36

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2014

0.37

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NTRS vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NTRS
NTRS Risk / Return Rank: 9393
Overall Rank
NTRS Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
NTRS Sortino Ratio Rank: 9393
Sortino Ratio Rank
NTRS Omega Ratio Rank: 9292
Omega Ratio Rank
NTRS Calmar Ratio Rank: 9393
Calmar Ratio Rank
NTRS Martin Ratio Rank: 9494
Martin Ratio Rank

ARKG
ARKG Risk / Return Rank: 5757
Overall Rank
ARKG Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 6262
Sortino Ratio Rank
ARKG Omega Ratio Rank: 5252
Omega Ratio Rank
ARKG Calmar Ratio Rank: 6363
Calmar Ratio Rank
ARKG Martin Ratio Rank: 4545
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NTRS vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Northern Trust Corporation (NTRS) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NTRSARKGDifference
Sharpe ratioReturn per unit of total volatility

+0.76

Sortino ratioReturn per unit of downside risk

+0.86

Omega ratioGain probability vs. loss probability

1.40

1.27

+0.14

Calmar ratioReturn relative to maximum drawdown

4.72

2.54

+2.18

Martin ratioReturn relative to average drawdown

13.12

6.04

+7.08

NTRS vs. ARKG - Sharpe Ratio Comparison

The current NTRS Sharpe Ratio is 2.39, which is higher than the ARKG Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of NTRS and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NTRS vs. ARKG - Drawdown Comparison

The maximum NTRS drawdown since its inception was -67.67%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for NTRS and ARKG.


Loading charts...

Drawdown Indicators


NTRSARKGDifference

Max Drawdown

Largest peak-to-trough decline

-67.67%

-83.59%

+15.92%

Max Drawdown (1Y)

Largest decline over 1 year

-12.39%

-27.51%

+15.12%

Max Drawdown (3Y)

Largest decline over 3 years

-25.21%

-51.96%

+26.75%

Max Drawdown (5Y)

Largest decline over 5 years

-50.03%

-79.26%

+29.23%

Max Drawdown (10Y)

Largest decline over 10 years

-50.03%

-83.59%

+33.56%

Current Drawdown

Current decline from peak

0.00%

-63.12%

+63.12%

Average Drawdown

Average peak-to-trough decline

-20.90%

-36.15%

+15.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.45%

11.53%

-7.08%

Volatility

NTRS vs. ARKG - Volatility Comparison

The current volatility for Northern Trust Corporation (NTRS) is 5.56%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 12.54%. This indicates that NTRS experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NTRSARKGDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.56%

12.54%

-6.98%

Volatility (6M)

Calculated over the trailing 6-month period

19.19%

31.33%

-12.14%

Volatility (1Y)

Calculated over the trailing 1-year period

24.61%

43.01%

-18.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.46%

46.10%

-16.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.20%

41.38%

-11.18%

Dividends

NTRS vs. ARKG - Dividend Comparison

NTRS's dividend yield for the trailing twelve months is around 1.67%, while ARKG has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%0.00%0.00%
NTRS
Northern Trust Corporation
1.67%2.27%2.93%3.56%3.28%2.34%3.01%2.45%2.32%1.60%1.66%1.96%

Frequently Asked Questions


NTRS and ARKG have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (12.54%) compared to NTRS (5.56%). In terms of maximum drawdown, NTRS dropped -67.67% vs ARKG's -83.59%.

NTRS currently has the higher Sharpe Ratio (2.39 vs 1.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NTRS and ARKG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer